| Biological Sciences | Lifetime | 87 | CN 3 | 99.99 |
| Medical and Health Sciences | Lifetime | 727 | CN 11 | 99.97 |
| Biological Sciences | 2021-2025 | 13 | CN 4 | 99.98 |
| Medical and Health Sciences | 2021-2025 | 95 | CN 9 | 99.98 |
| Economics and Finance | 2021-2025 | 1,000 | CN 182 | 95.86 |
| Literature, Linguistics and Cultural Studies | 2021-2025 | 743 | CN 67 | 93.51 |
| Genetics | Lifetime | 26 | CN 1 | 99.93 |
| Molecular Biology | Lifetime | 157 | CN 3 | 99.93 |
| Cancer Research | Lifetime | 116 | CN 4 | 99.38 |
| Epidemiology | Lifetime | 468 | CN 14 | 99.41 |
| Pulmonary and Respiratory Medicine | Lifetime | 762 | CN 16 | 98.85 |
| Oncology | Lifetime | 692 | CN 20 | 98.62 |
| Accounting | Lifetime | 535 | CN 24 | 98.59 |
| Educational Psychology and Assessment | Lifetime | 593 | CN 16 | 97.78 |
| Pathology and Forensic Medicine | Lifetime | 535 | CN 9 | 97.73 |
| Pharmacology | Lifetime | 264 | CN 18 | 97.59 |
| Pediatrics, Perinatology and Child Health | Lifetime | 781 | CN 11 | 97.46 |
| Immunology | Lifetime | 804 | CN 24 | 97.39 |
| Cell Biology | Lifetime | 698 | CN 13 | 95.80 |
| Rheumatology | Lifetime | 773 | CN 12 | 96.03 |
| Transportation | Lifetime | 865 | CN 139 | 93.65 |
| Complementary and Alternative Medicine | Lifetime | 684 | CN 55 | 94.38 |
| Cellular and Molecular Neuroscience | Lifetime | 943 | CN 20 | 95.19 |
| Financial Markets, Risk and Investment | Lifetime | 706 | CN 58 | 93.95 |
| Reproductive Medicine | Lifetime | 707 | CN 10 | 92.81 |
| Hepatology | Lifetime | 593 | CN 32 | 91.82 |
| Ophthalmology | Lifetime | 680 | CN 20 | 86.33 |
| Biotechnology | Lifetime | 733 | CN 48 | 84.12 |
| Biochemistry | Lifetime | 924 | CN 62 | 78.05 |
| Clinical Biochemistry | Lifetime | 813 | CN 16 | 77.95 |
| Pharmaceutical Science | Lifetime | 901 | CN 82 | 73.64 |
| Sensory Systems | Lifetime | 713 | CN 14 | 71.53 |
| Immunology and Allergy | Lifetime | 993 | CN 21 | 54.50 |
| Molecular Medicine | Lifetime | 656 | CN 74 | 50.97 |
| Molecular Biology | 2021-2025 | 14 | CN 7 | 99.94 |
| Genetics | 2021-2025 | 22 | CN 3 | 99.60 |
| Epidemiology | 2021-2025 | 63 | CN 6 | 99.64 |
| Surgery | 2021-2025 | 176 | CN 12 | 98.95 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 116 | CN 14 | 99.22 |
| Cancer Research | 2021-2025 | 34 | CN 16 | 98.62 |
| Immunology | 2021-2025 | 106 | CN 22 | 97.89 |
| Oncology | 2021-2025 | 203 | CN 24 | 98.41 |
| Medical Physiology | 2021-2025 | 325 | CN 18 | 95.62 |
| Public, Environmental and Occupational Health | 2021-2025 | 535 | CN 23 | 94.87 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 372 | CN 10 | 95.76 |
| Econometrics and Quantitative Economics | 2021-2025 | 847 | CN 173 | 94.50 |
| Plant Science | 2021-2025 | 484 | CN 158 | 94.40 |
| Cell Biology | 2021-2025 | 107 | CN 11 | 91.07 |
| Rheumatology | 2021-2025 | 257 | CN 13 | 91.97 |
| Radiology, Nuclear Medicine and Imaging | 2021-2025 | 452 | CN 47 | 90.78 |
| Health, Toxicology and Mutagenesis | 2021-2025 | 455 | CN 158 | 91.87 |
| Pediatrics, Perinatology and Child Health | 2021-2025 | 410 | CN 17 | 90.53 |
| Neuroscience of Neurology | 2021-2025 | 207 | CN 28 | 88.13 |
| Pathology and Forensic Medicine | 2021-2025 | 309 | CN 43 | 89.98 |
| Obstetrics and Gynecology | 2021-2025 | 358 | CN 15 | 79.71 |
| Psychiatry and Mental health | 2021-2025 | 834 | CN 23 | 65.37 |
| Cancer-related molecular mechanisms research | Lifetime | 14 | CN 5 | 99.87 |
| Molecular Biology Techniques and Applications | Lifetime | 6 | CN 1 | 99.72 |
| Forensic and Genetic Research | Lifetime | 4 | CN 1 | 99.85 |
| MicroRNA in disease regulation | Lifetime | 48 | CN 12 | 99.72 |
| Circular RNAs in diseases | Lifetime | 25 | CN 11 | 99.62 |
| RNA modifications and cancer | Lifetime | 135 | CN 7 | 99.59 |
| Genetic diversity and population structure | Lifetime | 105 | CN 3 | 99.42 |
| Race, Genetics, and Society | Lifetime | 6 | CN 1 | 98.19 |
| Genetic Associations and Epidemiology | Lifetime | 116 | CN 4 | 99.21 |
| Bioinformatics and Genomic Networks | Lifetime | 156 | CN 15 | 98.44 |
| Genetic Mapping and Diversity in Plants and Animals | Lifetime | 197 | CN 20 | 98.73 |
| Ferroptosis and cancer prognosis | Lifetime | 201 | CN 87 | 97.43 |
| Epigenetics and DNA Methylation | Lifetime | 649 | CN 50 | 98.47 |
| Gene expression and cancer classification | Lifetime | 157 | CN 15 | 98.14 |
| Genomic variations and chromosomal abnormalities | Lifetime | 212 | CN 5 | 98.33 |
| Cancer-related gene regulation | Lifetime | 351 | CN 32 | 98.13 |
| Genomics and Phylogenetic Studies | Lifetime | 668 | CN 38 | 98.41 |
| CRISPR and Genetic Engineering | Lifetime | 617 | CN 33 | 97.95 |
| Genomics and Rare Diseases | Lifetime | 283 | CN 7 | 97.46 |
| Hepatitis B Virus Studies | Lifetime | 828 | CN 48 | 97.96 |
| Folate and B Vitamins Research | Lifetime | 487 | CN 13 | 96.49 |
| Yersinia bacterium, plague, ectoparasites research | Lifetime | 233 | CN 8 | 96.54 |
| Cancer-related Molecular Pathways | Lifetime | 980 | CN 50 | 96.96 |
| Medicinal Plant Pharmacodynamics Research | Lifetime | 77 | CN 50 | 93.53 |
| Esophageal Cancer Research and Treatment | Lifetime | 787 | CN 34 | 96.31 |
| RNA regulation and disease | Lifetime | 758 | CN 26 | 94.58 |
| Forensic Anthropology and Bioarchaeology Studies | Lifetime | 424 | CN 8 | 95.75 |
| Atherosclerosis and Cardiovascular Diseases | Lifetime | 924 | CN 46 | 94.79 |
| Fibroblast Growth Factor Research | Lifetime | 534 | CN 36 | 93.61 |
| Kruppel-like factors research | Lifetime | 387 | CN 39 | 93.20 |
| Traditional Chinese Medicine Analysis | Lifetime | 536 | CN 400 | 93.29 |
| melanin and skin pigmentation | Lifetime | 695 | CN 23 | 94.09 |
| PI3K/AKT/mTOR signaling in cancer | Lifetime | 986 | CN 52 | 93.39 |
| IL-33, ST2, and ILC Pathways | Lifetime | 827 | CN 34 | 93.06 |
| Nutrition, Genetics, and Disease | Lifetime | 915 | CN 24 | 91.67 |
| Chemical Reactions and Isotopes | Lifetime | 890 | CN 16 | 92.70 |
| Traditional Chinese Medicine Studies | Lifetime | 762 | CN 449 | 88.40 |
| Cardiac Fibrosis and Remodeling | Lifetime | 737 | CN 74 | 91.66 |
| Corporate Taxation and Avoidance | Lifetime | 775 | CN 39 | 91.06 |
| High Altitude and Hypoxia | Lifetime | 833 | CN 25 | 92.01 |
| Alkaloids: synthesis and pharmacology | Lifetime | 789 | CN 118 | 87.95 |
| Connective Tissue Growth Factor Research | Lifetime | 470 | CN 43 | 82.42 |
| Berberine and alkaloids research | Lifetime | 874 | CN 311 | 79.70 |
| GDF15 and Related Biomarkers | Lifetime | 724 | CN 53 | 77.52 |
| China's Ethnic Minorities and Relations | Lifetime | 609 | CN 110 | 76.54 |
| Mechanisms of cancer metastasis | Lifetime | 574 | CN 111 | 69.96 |
| Tannin, Tannase and Anticancer Activities | Lifetime | 903 | CN 99 | 61.88 |
| Dermatoglyphics and Human Traits | Lifetime | 750 | CN 77 | 50.92 |
| Cancer-related molecular mechanisms research | 2021-2025 | 21 | CN 14 | 99.72 |
| RNA modifications and cancer | 2021-2025 | 63 | CN 44 | 99.17 |
| Ferroptosis and cancer prognosis | 2021-2025 | 200 | CN 159 | 96.75 |
| Liver Disease Diagnosis and Treatment | 2021-2025 | 502 | CN 54 | 97.69 |
| Gastric Cancer Management and Outcomes | 2021-2025 | 494 | CN 94 | 96.11 |
| Immune cells in cancer | 2021-2025 | 323 | CN 177 | 93.98 |
| Adipose Tissue and Metabolism | 2021-2025 | 362 | CN 70 | 92.75 |
| Sepsis Diagnosis and Treatment | 2021-2025 | 345 | CN 31 | 94.53 |
| RNA Interference and Gene Delivery | 2021-2025 | 403 | CN 205 | 94.10 |
| Cancer-related gene regulation | 2021-2025 | 204 | CN 135 | 91.21 |
| Genetic Mapping and Diversity in Plants and Animals | 2021-2025 | 264 | CN 84 | 93.13 |
| Colorectal Cancer Treatments and Studies | 2021-2025 | 436 | CN 41 | 94.71 |
| MicroRNA in disease regulation | 2021-2025 | 748 | CN 457 | 92.63 |
| Adipokines, Inflammation, and Metabolic Diseases | 2021-2025 | 208 | CN 40 | 89.95 |
| interferon and immune responses | 2021-2025 | 299 | CN 162 | 89.90 |
| Genetic diversity and population structure | 2021-2025 | 322 | CN 51 | 92.03 |
| Atherosclerosis and Cardiovascular Diseases | 2021-2025 | 205 | CN 26 | 90.77 |
| Genomics and Phylogenetic Studies | 2021-2025 | 774 | CN 216 | 90.96 |
| Gastrointestinal Tumor Research and Treatment | 2021-2025 | 344 | CN 81 | 91.43 |
| Genetic Associations and Epidemiology | 2021-2025 | 515 | CN 57 | 91.03 |
| Forensic and Genetic Research | 2021-2025 | 137 | CN 39 | 90.28 |
| Molecular Biology Techniques and Applications | 2021-2025 | 212 | CN 70 | 85.87 |
| Inflammasome and immune disorders | 2021-2025 | 462 | CN 217 | 88.30 |
| Neuroinflammation and Neurodegeneration Mechanisms | 2021-2025 | 981 | CN 308 | 88.85 |
| Metabolomics and Mass Spectrometry Studies | 2021-2025 | 820 | CN 249 | 87.54 |
| melanin and skin pigmentation | 2021-2025 | 213 | CN 48 | 86.78 |
| Genetic factors in colorectal cancer | 2021-2025 | 781 | CN 66 | 88.09 |
| Kruppel-like factors research | 2021-2025 | 95 | CN 22 | 86.78 |
| Circular RNAs in diseases | 2021-2025 | 833 | CN 597 | 86.81 |
| RNA regulation and disease | 2021-2025 | 318 | CN 78 | 82.79 |
| Autophagy in Disease and Therapy | 2021-2025 | 694 | CN 336 | 85.06 |
| Folate and B Vitamins Research | 2021-2025 | 345 | CN 97 | 81.70 |
| Plant Taxonomy and Phylogenetics | 2021-2025 | 110 | CN 26 | 82.06 |
| Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities | 2021-2025 | 345 | CN 135 | 82.44 |
| IL-33, ST2, and ILC Pathways | 2021-2025 | 621 | CN 72 | 79.50 |
| S100 Proteins and Annexins | 2021-2025 | 318 | CN 47 | 76.44 |
| Bioinformatics and Genomic Networks | 2021-2025 | 955 | CN 302 | 77.91 |
| Health, Environment, Cognitive Aging | 2021-2025 | 783 | CN 77 | 79.61 |
| Heme Oxygenase-1 and Carbon Monoxide | 2021-2025 | 321 | CN 137 | 77.48 |
| Connexins and lens biology | 2021-2025 | 191 | CN 51 | 77.29 |
| Peroxisome Proliferator-Activated Receptors | 2021-2025 | 399 | CN 137 | 72.64 |
| Yersinia bacterium, plague, ectoparasites research | 2021-2025 | 415 | CN 73 | 71.93 |
| Biomarkers in Disease Mechanisms | 2021-2025 | 201 | CN 80 | 71.35 |
| Traditional Chinese Medicine Studies | 2021-2025 | 347 | CN 257 | 72.58 |
| Cytokine Signaling Pathways and Interactions | 2021-2025 | 991 | CN 317 | 65.96 |
| ATP Synthase and ATPases Research | 2021-2025 | 762 | CN 105 | 61.53 |
| TGF-β signaling in diseases | 2021-2025 | 213 | CN 63 | 58.96 |
| Race, Genetics, and Society | 2021-2025 | 131 | CN 12 | 55.02 |
| Congenital limb and hand anomalies | 2021-2025 | 165 | CN 24 | 52.34 |
| Protein Tyrosine Phosphatases | 2021-2025 | 716 | CN 158 | 45.00 |
| Wnt/β-catenin signaling in development and cancer | 2021-2025 | 937 | CN 270 | 42.35 |
| Chinese history and philosophy | 2021-2025 | 761 | CN 234 | 39.08 |
| Bioactive natural compounds | 2021-2025 | 594 | CN 239 | 40.15 |
| Language and cultural evolution | 2021-2025 | 499 | CN 10 | 26.07 |